These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 17550142

  • 21. Polymorphism (ALA16VAL) correlates with regional lymph node status in breast cancer.
    Bica CG, da Silva LL, Toscani NV, Zettler CG, Gottlieb MG, Alexandre CO, Graudenz MS, Mânica da Cruz IB.
    Cancer Genet Cytogenet; 2010 Jan 15; 196(2):153-8. PubMed ID: 20082851
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.
    Inoue H, Shibuta K, Matsuyama A, Yoshinaga K, Sadanaga N, Ueo H, Barnard GF, Mori M.
    Oncol Rep; 2005 Sep 15; 14(3):707-12. PubMed ID: 16077979
    [Abstract] [Full Text] [Related]

  • 25. CCND1 and CDKN1B polymorphisms and risk of breast cancer.
    Canbay E, Eraltan IY, Cercel A, Isbir T, Gazioglu E, Aydogan F, Cacina C, Cengiz A, Ferahman M, Zengin E, Unal H.
    Anticancer Res; 2010 Jul 15; 30(7):3093-8. PubMed ID: 20683061
    [Abstract] [Full Text] [Related]

  • 26. The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women.
    Spurdle AB, Hopper JL, Chen X, Dite GS, McCredie MR, Giles GG, Venter DJ, Southey MC, Purdie DM, Chenevix-Trench G.
    Cancer Epidemiol Biomarkers Prev; 2001 Dec 15; 10(12):1287-93. PubMed ID: 11751447
    [Abstract] [Full Text] [Related]

  • 27. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
    Bedewy AM, Mostafa MH, Saad AA, El-Maghraby SM, Bedewy MM, Hilal AM, Kandil LS.
    J BUON; 2013 Dec 15; 18(1):227-38. PubMed ID: 23613410
    [Abstract] [Full Text] [Related]

  • 28. Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk.
    Akisik E, Dalay N.
    Exp Mol Pathol; 2004 Jun 15; 76(3):260-3. PubMed ID: 15126109
    [Abstract] [Full Text] [Related]

  • 29. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.
    Cui Y, Shu XO, Cai Q, Jin F, Cheng JR, Cai H, Gao YT, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2005 May 15; 14(5):1096-101. PubMed ID: 15894658
    [Abstract] [Full Text] [Related]

  • 30. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
    Yaylim-Eraltan I, Ergen A, Görmüs U, Arikan S, Küçücük S, Sahin O, Yigit N, Yildiz Y, Isbir T.
    In Vivo; 2009 May 15; 23(5):767-72. PubMed ID: 19779113
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
    Siddig A, Mohamed AO, Kamal H, Awad S, Hassan AH, Zilahi E, Al-Haj M, Bernsen R, Adem A.
    Ann N Y Acad Sci; 2008 Sep 15; 1138():84-94. PubMed ID: 18837888
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer.
    Papadopoulou E, Simopoulos K, Tripsianis G, Tentes I, Anagnostopoulos K, Sivridis E, Galazios G, Kortsaris A.
    Neoplasma; 2007 Sep 15; 54(5):365-73. PubMed ID: 17918664
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women.
    Li H, Feng L, Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, Lin B, Li J, Xie Y.
    Acta Oncol; 2006 Sep 15; 45(5):597-601. PubMed ID: 16864175
    [Abstract] [Full Text] [Related]

  • 37. Polymorphic variant Ser128Arg of E-Selectin is associated with breast cancer risk and high grade tumors.
    Naidu R, Har YC, Taib NA.
    Onkologie; 2011 Sep 15; 34(11):592-7. PubMed ID: 22104155
    [Abstract] [Full Text] [Related]

  • 38. A case-control study of the HER2 Ile655Val polymorphism and risk of breast cancer in Taiwan.
    Lee SC, Hou MF, Hsieh PC, Wu SH, Hou LA, Ma H, Tsai SM, Tsai LY.
    Clin Biochem; 2008 Feb 15; 41(3):121-5. PubMed ID: 18062925
    [Abstract] [Full Text] [Related]

  • 39. Integrin beta3 Leu33Pro polymorphism and breast cancer risk: a population-based case-control study in Germany.
    Wang-Gohrke S, Chang-Claude J.
    Breast Cancer Res Treat; 2004 Dec 15; 88(3):231-7. PubMed ID: 15609125
    [Abstract] [Full Text] [Related]

  • 40. Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival.
    Tommiska J, Eerola H, Heinonen M, Salonen L, Kaare M, Tallila J, Ristimäki A, von Smitten K, Aittomäki K, Heikkilä P, Blomqvist C, Nevanlinna H.
    Clin Cancer Res; 2005 Jul 15; 11(14):5098-103. PubMed ID: 16033823
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.